A night after Carlos Alcaraz fell in the second round, the 24-time Grand Slam champion was taken out in the third.
Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-314 clinical trial evaluating Jaypirca ...
Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results